HUM241220C225000
- 8.50
- -8.70-50.58%
Humana Newsroom
Baird Adjusts Humana Price Target to $270 From $374, Maintains Neutral Rating
Trump's tariff plan is unpopular! More than half of the USA population opposes imposing taxes on commodities from Mexico.
①The plan of the USA's incoming president Trump to impose tariffs does not seem to be popular among the public. According to a poll, 51% of USA voters oppose imposing tariffs on commodities from Mexico, Canada, and China; ②Standard & Poor's states that USA tariffs will increase inflation rates and reduce economic output, while some citizens and businesses are stockpiling goods due to tariff concerns, leading to a significant increase in throughput at the ports of Los Angeles and Long Beach in November.
Tesla, Bitcoin, S&P 500, Dow, Tank: Thanks a Lot FOMC | Wall Street Today
Express News | FOMC Cuts Interest Rates by 25 Basis Points, Sees Fewer Reductions Next Year
Dow Breaks Downward Spiral, with FOMC Rate Cut on Deck | Live Stock
Stocks Down 10% or More: Humana, Marvell, and Amentum
Deutsche Says Humana Most at Risk From DOGE Targeting Medicare Overlap
Tuesday, Tech Pulls Back, While Traders Await FOMC Rate | Wall Street Today
Clover Health Draws New Buy at Craig-Hallum Despite Sharp YTD Gains
Top Stock Movers Now: Amentum Holdings, Humana, Nvidia, and More
Humana Is Maintained at Equal-Weight by Morgan Stanley
Stocks Slip As Strong November Retail Sales Raise Concerns Over 2025 Fed Rate Cuts
Humana Analyst Ratings
Tuesday Tech Pull Back After Nasdaq and Bitcoin Record | Live Stock
Morgan Stanley Adjusts Price Target on Humana to $301 From $288
Morgan Stanley Maintains Humana(HUM.US) With Hold Rating, Raises Target Price to $301
Morgan Stanley Sticks to Their Hold Rating for Humana (HUM)
Piper Sandler Maintains Humana(HUM.US) With Hold Rating, Cuts Target Price to $270
Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), Alcon (ALC) and Humana (HUM)
Express News | Humana Inc Shares Hit Lowest Level Since Early Nov, Last Down 3.4% at $264.87